$11.18
8.21% yesterday
Nasdaq, Jun 12, 10:00 pm CET
ISIN
US15687V1098
Symbol
CERT

Certara Stock price

$11.18
-0.95 7.83% 1M
-0.53 4.53% 6M
+0.53 4.98% YTD
-4.37 28.10% 1Y
-26.90 70.64% 5Y
-26.90 70.64% 10Y
-26.90 70.64% 20Y
Nasdaq, Closing price Thu, Jun 12 2025
-1.00 8.21%
ISIN
US15687V1098
Symbol
CERT

Key metrics

Market capitalization $1.81b
Enterprise Value $1.93b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 27.45
EV/Sales (TTM) EV/Sales 4.89
P/S ratio (TTM) P/S ratio 4.60
P/B ratio (TTM) P/B ratio 1.66
Revenue growth (TTM) Revenue growth 9.37%
Revenue (TTM) Revenue $394.50m
EBIT (operating result TTM) EBIT $7.18m
Free Cash Flow (TTM) Free Cash Flow $70.29m
Cash position $179.09m
EPS (TTM) EPS $-0.02
P/E forward negative
P/S forward 4.31
EV/Sales forward 4.58
Short interest 6.79%
Show more

Is Certara a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Certara Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Certara forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Certara forecast:

Buy
50%
Hold
50%

Financial data from Certara

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
395 395
9% 9%
100%
- Direct Costs 157 157
8% 8%
40%
238 238
10% 10%
60%
- Selling and Administrative Expenses 140 140
5% 5%
36%
- Research and Development Expense 36 36
3% 3%
9%
62 62
3,348% 3,348%
16%
- Depreciation and Amortization 55 55
15% 15%
14%
EBIT (Operating Income) EBIT 7.18 7.18
115% 115%
2%
Net Profit -2.63 -2.63
96% 96%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Certara directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Certara Stock News

Neutral
Seeking Alpha
about one month ago
Certara, Inc. (NASDAQ:CERT ) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants David Deuchler - Investor Relations, Gilmartin Group LLC William Feehery - Chief Executive Officer John Gallagher - Chief Financial Officer Conference Call Participants Dan Clark - Leerink Partners Joe Vruwink - Baird Scott Schoenhaus - KeyBanc Capital Markets David Windley - Jefferies Dan L...
Neutral
GlobeNewsWire
about one month ago
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025.
Neutral
GlobeNewsWire
about one month ago
RADNOR, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
More Certara News

Company Profile

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Head office United States
CEO William Feehery
Employees 1,365
Founded 2008
Website www.certara.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today